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Impact of Exercise on Cardiometabolic
Component Risks in Spinal
Cord–injured Humans
TOM E. NIGHTINGALE, JEAN-PHILIPPE WALHIN, DYLAN THOMPSON, and JAMES L. J. BILZON
Department for Health, University of Bath, Bath, Somerset, UNITED KINGDOM
ABSTRACT
NIGHTINGALE, T. E., J.-P. WALHIN, D. THOMPSON, and J. L. J. BILZON. Impact of Exercise on Cardiometabolic Component
Risks in Spinal Cord–injured Humans.Med. Sci. Sports Exerc., Vol. 49, No. 12, pp. 2469–2477, 2017. Purpose: Spinal cord injury (SCI)
creates a complex pathology, characterized by low levels of habitual physical activity and an increased risk of cardiometabolic disease.
This study aimed to assess the effect of a moderate-intensity upper-body exercise training intervention on biomarkers of cardiometabolic
component risks, adipose tissue metabolism, and cardiorespiratory fitness in persons with SCI.Methods: Twenty-one inactive men and
women with chronic (91 yr) SCI (all paraplegic injuries) 47 T 8 yr of age (mean T SD) were randomly allocated to either a 6-wk
prescribed home-based exercise intervention (INT; n = 13) or control group (CON; n = 8). Participants assigned to the exercise group completed
4  45-min moderate-intensity (60%–65% peak oxygen uptake (V˙O2peak)) arm-crank exercise sessions per week. At baseline and follow-up,
fasted and postload blood samples (collected during oral glucose tolerance tests) were obtained to measure metabolic regulation and bio-
markers of cardiovascular disease. Abdominal subcutaneous adipose tissue biopsies were also obtained, and cardiorespiratory fitness was
assessed. Results: Compared with CON, INT significantly decreased (P = 0.04) serum fasting insulin ($, 3.1 T 10.7 pmolILj1 for CON and
j12.7 T 18.7 pmolILj1 for INT) and homeostasis model assessment of insulin resistance (HOMA2-IR; $, 0.06 T 0.20 for CON and j0.23 T
0.36 for INT). The exercise group also increased V˙O2peak ($, 3.4 mLIkg
j1Iminj1; P e 0.001). Adipose tissue metabolism, composite insulin
sensitivity index (C-ISIMatsuda), and other cardiovascular disease risk biomarkers were not different between groups.Conclusions: Moderate-
intensity upper-body exercise improved aspects of metabolic regulation and cardiorespiratory fitness. Changes in fasting insulin and
HOMA2-IR, but not C-ISIMatsuda, suggest improved hepatic but not peripheral insulin sensitivity after 6 wk of exercise training in persons
with chronic paraplegia. Key Words: GENE EXPRESSION, INSULIN SENSITIVITY, PARAPLEGIA, MODERATE-INTENSITY
EXERCISE, METABOLIC HEALTH, CARDIOVASCULAR FITNESS
E
pidemiological studies suggest that mortality and mor-
bidity rates associated with cardiovascular disease and
Type 2 diabetes are elevated in individuals with spinal
cord injury (SCI) relative to adults without physical disabilities
(11,19). Risk factors for developing these chronic diseases,
including increased central adiposity (9), reduced HDL
cholesterol (13), and impaired glucose tolerance (2), occur at
a heightened frequency in this population. One modifiable
lifestyle factor, widely accepted to influence the incidence of
these noncommunicable diseases in the general population and
often not performed regularly in persons with SCI (3), is physical
activity. It is therefore intuitive to suggest that exercise may play
a beneficial role in improving cardiometabolic component risks
in the SCI population.
Although upper-body aerobic exercise in this population
improves strength and cardiorespiratory fitness, its effect on
cardiometabolic component risks in adults with SCI remains
unclear (4). Adhering to the current Physical Activity Guidelines
for Spinal Cord Injury (PAG-SCI: 940 min minIwkj1
moderate- to vigorous-intensity aerobic exercise) failed to im-
prove biomarkers of cardiovascular disease (8). With voluntary
movements restricted to the smaller upper-body skeletal mus-
cles of persons with SCI, achieving the same energy expendi-
ture as moderate-intensity whole-body exercise might require a
greater volume of exercise to stimulate similar physiologi-
cal adaptations. Whether a larger volume of exercise, above
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that recommended for the general population, is capable of
improving cardiometabolic component risks in persons with
SCI has yet to be established.
Evidence suggests that two of three people with SCI are
obese (12). Given its role in lipid storage and its function as
an endocrine organ (36), adipose tissue may play a promi-
nent role in regulating whole-body adaptations to exercise
training in persons with SCI. Animal models suggest that ex-
ercise training results in wide-ranging and multifunctional ad-
aptations to subcutaneous adipose tissue, including increased
expression of several key metabolic proteins (33,35). Interest-
ingly, daily vigorous-intensity treadmill running has been shown
to counteract the negative effects of short-term weight gain at
the whole-body level and in adipose tissue in healthy young
men (39). Therefore, exercise may also have beneficial effects
on whole-body and adipose tissue metabolism in persons
with SCI. Exercise interventions may serve as a preventive
measure in SCI patients, reducing the burden of long-term
chronic disease in this population.
The aim of this study was to determine the effect of
moderate-intensity exercise on cardiometabolic component
risks, the expression of key genes within adipose tissue, and
cardiorespiratory fitness in persons with chronic paraplegia.
We hypothesized that, in comparison to a control group, 6 wk
of home-based moderate-intensity exercise would improve (i)
metabolic regulation, (ii) biomarkers of cardiovascular dis-
ease, (iii) adipose tissue metabolism, and (iv) cardiorespira-
tory fitness in persons with SCI.
METHODS
HOMEX-SCI (ISRCTN57096451) is a randomized con-
trolled trial that compares the effect of moderate-intensity
upper-body home-based exercise (INT) relative to a control
group (CO) on health indices and adipose tissuemetabolism in
persons with chronic SCI. The trial protocol was approved by
the South West (Exeter) National Research Ethics Service
Committee (14/SW/0106), and all participants provided writ-
ten informed consent. A detailed trial protocol has since been
published (26) and is in accordance with current Consolidated
Standards of Reporting Trials (CONSORT) guidelines (31)
(Fig. 1). The same experimental procedures were performed
during both baseline and follow-up laboratory testing.
Participants. Study participants who met the following
criteria were included in the study: 18–65 yr of age, male or
female, inactive (habitual physical activity level (PAL)
e1.60), with chronic (91 yr) paraplegia at or below T2, no
immediate plans to alter diet and/or physical activity behavior,
weight stable (T3 kg during the previous 6 months), free from
active medical issues (i.e., pressure sores, urinary tract in-
fections, and cardiovascular contraindications for testing) or
musculoskeletal complaints, and not taking antihyperglycemic
medication. Participants with neurologically incomplete inju-
ries were considered eligible provided that they used a wheel-
chair 975% of their waking day. Baseline demographic and
anthropometric characteristics of participants who completed
the trial are presented in Table 1.
Experimental design and protocol. Anthropometric
characteristics are as follows: supine height (Lufkin, Sparks,
MD), body mass (Detecto BRW1000, Webb City, MO),
fat mass, lean mass, and visceral adipose tissue area (dual-
energy x-ray absorptiometry; Discovery, Hologic, Bedford,
UK) were determined at 0830 T 1 h. Although the participants
remained in a 10-h overnight fast, resting metabolic rate was
measured in a supine position via indirect calorimetry from
expired gasses. A 20-mL blood sample was drawn from an
antecubital vein via an indwelling cannula (BD Venflon Pro;
BD, Helsingborg, Sweden), with separated samples of serum
and plasma immediately cooled on dry ice and stored at
j80-C. A small (1–2 g) subcutaneous adipose tissue biopsy
performed under local anesthesia (1% lignocaine hydrochlo-
ride) was then sampled from the abdomen using an established
FIGURE 1—CONSORT flow diagram for HOMEX-SCI trial.
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‘‘needle aspiration’’ technique. The sample was cleaned with
isotonic saline, and any clots were manually removed. Once
the sample had been weighed, it was homogenized in 5 mL of
TRIzol (Invitrogen, Paisley, UK) and placed on dry ice until
being stored atj80-C. After these procedures, an oral glucose
tolerance test (OGTT) was performed, whereby the participants
ingested 75 g of anhydrous glucose in a Polycal solution
(Nutrica, Trowbridge, UK) within 5 min. Once ingested, 5-mL
blood samples were collected every 15 min for 2 h. Blood
pressure was also measured in triplicate using an automated
monitor (Boso Medicus Prestige; Bosch + Sohn GmbH,
Jungingen, Germany).
After these resting measurements, participants’ subpeak
and peak physiological responses to arm-crank ergometry
were assessed. Participants undertook a discontinuous, in-
cremental subpeak test on the same portable desktop er-
gometer (Monark 871E, Dalarna, Sweden) provided to them
during the INT. Peak oxygen uptake (V˙O2peak) and work-
load were measured at the point of volitional exhaustion
during a continuous, incremental exercise protocol (26)
performed on an electrically braked arm-crank ergometer
(Lode Angio, Groningen, the Netherlands). During both of
these exercise protocols, expired gasses were continuously
analyzed using a calibrated computerized metabolic system
(TrueOne 2400; ParvoMedics, Salt Lake City, UT). Heart
rate was also recorded using a heart rate monitor (T31; Polar
Electro Inc., Lake Success, NY). Investigators conducting the
V˙O2peak test were not blinded to group allocation because of lo-
gistical considerations of managing the trial, but verbal encour-
agement was standardized between baseline and follow-up.
For 7 d after baseline laboratory testing, participants’ free-
living habitual energy intake (weighed-food diaries) and
energy expenditure (individually calibratedActiHearti) were
estimated. To estimate energy intake, participants were pro-
vided with a set of weighing scales (PL11B; Smart Weigh,
Chestnut Ridge, NY) and trained by the experimenters during
the baseline trial how to record food intake. Diet records were
analyzed using Nutritics software (Nutritics Ltd., Dublin,
Ireland), to estimate energy intake and macronutrient com-
position. To estimate energy expenditure, participants wore a
chest-mountedActihearti device (CambridgeNeurotechnology
Ltd., Papworth, UK), individually calibrated for each partici-
pant using heart rate data collected at rest and during labora-
tory exercise testing (26). One participant was excluded (PAL
91.60) from the study. During the 6-wk intervention, eligible
participants were randomly assigned (2/1 allocation ratio) to
home-based moderate-intensity upper-body exercise (INT) or a
lifestyle maintenance (CON). Minimization was used to ensure
balance between the two groups for baseline characteristics of
age, body mass, level of spinal cord lesion, and PAL. The 6-wk
intervention period began ~2wk after baseline laboratory testing
to account for free-living assessment; returning, downloading,
and analyzing data for participant eligibility; and delivery of
portable arm-crank ergometer. During this 2-wk interim period,
participants were instructed not to alter their normal activity
patterns or dietary behaviors. Consequently, there were ~8 wk
between baseline and follow-up testing, ensuring that
eumenorrheic (n = 3) female participants were in the follicular
phase of their menstrual cycle for both laboratory visits. Be-
sides providing the necessary tools for free-living assessment
and arranging follow-up testing, investigator contact with the
CON group was negligible to minimize any potential effect
on participant behavior.
Home-based exercise intervention. The INT group
performed moderate-intensity exercise four times per week
on a portable desktop arm-crank ergometer in their own
home. The duration of each exercise session was extended by
5 min per session throughout the first week (i.e., from 30 to
45 min). The exercise intensity was also increased from
~60% V˙O2peak during the first 3 wk to ~65% V˙O2peak for
the final 3 wk. The first exercise session was supervised by
an experimenter to ensure that the arm-crank ergometer was
set up appropriately and the correct duration and intensity of
exercise were adhered to. Compliance with subsequent ses-
sions was monitored via a GENEActiv triaxial accelerometer
(Activinsights, Cambridge, UK) worn on the wrist. During the
final week of the intervention, energy intake and expenditure
were estimated again. No dietary constraints were imposed.
The last bout of exercise in the INT group was 936 h before
follow-up laboratory testing.
Blood and adipose tissue analysis. Key systemic
metabolites and hormones were measured via commercially
available spectrophotometric assays (serum triacylglycerol,
total cholesterol and HDL cholesterol, nonesterified fatty
acids (NEFA), and plasma glucose fromRandox Laboratories,
Co., Antrim, UK) and enzyme-linked immunosorbent assays
(serum insulin; Mercodia AB, Uppsala, Sweden). Adipose
tissue samples were defrosted and the aqueous phase was
TABLE 1. Baseline demographic and anthropometric characteristics.
CON (n = 8) INT (n = 13)
Sex, M/Fa 6/2 9/4
Age, yr 48 T 10 46 T 6
Height, m 1.73 T 0.08 1.72 T 0.08
Body mass, kg 76.8 T 11.3 76.8 T 13.3
Fat mass, kg 25.5 T 6.6 27.6 T 10.0
PAL 1.38 T 0.12 1.35 T 0.10
Injury
AIS A–Ba 7 (87) 11 (85)
AIS C–Da 1 (13) 2 (15)
Lesion level T4–L3 T4–L1
QT6 4 (50) 5 (38)
GT6 4 (50) 8 (62)
TSI, yr 20 T 10 14 T 11
Medication usea
Neuropathic pain 2 (25) 5 (38)
Neurogenic bladder 2 (25) 2 (26)
Muscle spasms 0 (0) 3 (23)
Constipation 1 (13) 1 (8)
Antihypertensives 1 (13) 1 (8)
Antidepressants 1 (13) 1 (8)
Lipid-lowering agents 0 (0) 1 (8)
Values are n, mean T SD, or n (%). No variable differed significantly between groups at
baseline (P 9 0.14).
aFor frequency data, two-sample tests for equality of proportions without continuity correction
were performed in R (version 3.2.4; R Foundation for Statistical Computing, Vienna, Austria).
AIS, American Spinal Injury Association Impairment Scale; F, female; M, male; PAL, total
energy expenditure/resting energy expenditure; TSI, time since injury; T6, sixth thoracic
vertebrae.
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mixed with an equal volume of 70% ethanol before being
loaded onto an RNeasy mini-column for extraction (Qiagen,
Crawley, UK). The amount of RNA was quantified using
spectrophotometry, with 2 Kg of total RNA reverse tran-
scribed using a high-capacity cDNA reverse transcription kit
(Applied Biosystems, Warrington, UK). Assays from Applied
Biosystems were used, as follows: adipose triglyceride lipase
(ATGL; Hs00386101), fatty acid synthase (Hs00188012_m1),
hormone-sensitive lipase (Hs00193510), lipoprotein lipase
(Hs01012567_m1), sterol regulatory element binding protein
1c (Hs01088691_m1), 5¶-AMP–activated protein kinase
(AMPK; Hs01562315_m1 and Hs00178903_m1, combined),
glucose transporter type 4 (GLUT4; Hs00168966_m1), insulin
receptor substrate 2 (Hs00275843_s1), pyruvate dehydroge-
nase kinase isozyme (Hs00176875_m1), and peroxisome
proliferator–activated receptor gamma coactivator 1-alpha
(PGC-1>; Hs01016719_m1). Peptidylpropyl isomerase A
(PPIA) was used as an endogenous control, with real-time
polymerase chain reaction performed using a StepOnei
(Applied Biosystems). Data were processed using the com-
parative threshold cycle (Ct) method ($Ct = Ct target gene j
Ct endogenous control) and normalized to an internal calibrator
and baseline.
Statistical analyses. Serial measurements of glucose
and insulin responses to the OGTT at baseline and follow-up
were converted into simple summary statistics (i.e., within-
subject fasting concentrations, incremental area under the curve,
and indices of insulin sensitivity/resistance). Responses within
and between trials were analyzed by two-way (group–day)
mixed-model ANOVA. ANOVA was performed irrespective
of any minor deviations from a normal distribution but with
Greenhouse–Geisser corrections applied to intraindividual
contrasts, where ? G 0.75, and the Huynh–Feldt corrections ap-
plied for less severe asphericity. Where significant interaction
effects were observed, paired t-tests were applied to determine
significant differences within groups. As a subgroup analysis,
participants in the INT group were stratified into two groups,
injury levels of QT6 and GT6, to assess whether cardiometabolic
component risk outcomes responded differently to exercise
training. Standardized effect sizes (Cohen d) were also calculated
and reported for variables with significant effects. On the basis
of the magnitude of correlation between trials, thresholds of 90.2
(small), 90.5 (moderate), and 90.8 (large) were used. Statistical
analysis for the gene expression data was carried out on the log-
transformed data after normalization to an internal calibrator and
baseline (21). Independent t-tests were calculated between
groups for all baseline variables. Statistical analyses were
performed using SPSS version 22 (IBM, Armonk, NY), with
statistical significance accepted at a priori of > e 0.05. Values
are means with SD in text and tables, with effects expressed as
change ($) scores with 95% confidence intervals (CI).
RESULTS
Of the 24 participants who were randomized to either the
INT (n = 16) or CON (n = 8) group, 21 participants (13 INT,
8 CON) were retained for data analyses. The reasons for
exclusion were illness/infection (n = 1) and lack of adher-
ence to the intervention (n = 2). In the INT group, 12 of 13
participants completed all 24 training sessions, that is, 100%
compliance. One participant missed two nonconsecutive
sessions over the course of 6 wk (92% compliance). During
the 6-wk period, mean subjective ratings of difficulty for the
INT group across all exercise sessions was 7 T 1 (1, easy; 10,
hard), mean exercise session duration was 44 T 1 min, and
mean power output was 46 T 18 W. Measured mean exercise
heart rate was 144 T 11 bpm.
Free-living energy expenditure and intake. The
moderate-intensity upper-body exercise intervention signifi-
cantly (P e 0.01) increased physical activity energy expenditure
(PAEE) and minutes spent performing moderate-to-vigorous
intensity physical activity (Q3 METs) relative to the CON
group (Table 2). In the INT group, objectively measured
PAEE was 109 T 85 kcalIdj1 higher (P e 0.001) relative to
baseline. Energy intake and macronutrient composition did
not change over time (P 9 0.2), with no evidence of an in-
teraction effect (P 9 0.2).
Body composition. Body composition and resting
physiological measures at baseline and follow-up are sum-
marized in Table 2. Body mass significantly decreased from
baseline to follow-up when all participants in both groups
were considered (P e 0.05). The absolute change was not
different between the INT (j1.1 kg; 95%CI,j2.1 toj0.0 kg)
and CON (j0.7 kg; 95% CI,j2.2 to 1.0 kg) groups (P = 0.6).
Body mass changes were predominantly explained by re-
ductions in fat mass (j0.6; 95% CI, j1.4 to 0.2 kg) and lean
mass (j0.5 kg; 95% CI,j1.4 to 0.5 kg) in the INT and CON
groups, respectively.
Functional capacity (V˙O2peak and power output). Func-
tional capacity in terms of V˙O2peak (Fig. 2A) and power out-
put (Fig. 2B) significantly increased over time (P e 0.001),
with evidence of a strong interaction effect (P e 0.001).
The INT group significantly increased (P e 0.001) V˙O2peak
(3.4 mLIkgj1Iminj1; 95% CI, 2.4–4.3 mLIkgj1Iminj1) and
peak power output (19 W; 95% CI, 14–23 W), whereas these
outcomes remained unchanged in the CON group.
Metabolic regulation. Markers of metabolic regulation
at baseline and follow-up are summarized in Table 3.
Changes in fasting serum insulin concentrations and the
homeostasis model assessment of insulin resistance (HOMA2-IR)
were different between the two groups (P e 0.044). The INT
group significantly decreased fasting serum insulin concentra-
tions (j12.7 pmolILj1; 95% CI,j24.0 toj1.4 pmolILj1; P e
0.031) and HOMA2-IR (j0.24; 95% CI,j0.45 toj0.02; P e
0.035), whereas these outcomes were unchanged in the CON
group. There was a trend for an interaction effect (P = 0.066) for
homeostasis model assessment of pancreatic A-cell function
(HOMA2-A). Fasting plasma glucose and measures derived
during the OGTT (composite insulin sensitivity index (C-
ISIMatsuda), plasma glycemic response, and serum insulinemic
response) were not different over time (all P Q 0.6), with no
interaction effects (all P Q 0.3).
http://www.acsm-msse.org2472 Official Journal of the American College of Sports Medicine
A
PP
LI
ED
SC
IE
N
C
ES
Cardiometabolic component risks. Biomarkers of
cardiovascular disease risk (Table 3) did not respond differently
to 6 wk of INT or CON (all interactions; P 9 0.3), although
there was a trend for an interaction effect (P = 0.054) for serum
triacylglycerol concentration. Within the INT group, mean
$ change values for total cholesterol and LDL cholesterol
increased in participants with injury level of QT6 (0.35 and
0.26 mmolILj1, respectively) and decreased in the GT6 group
(j0.29 and j0.23 mmolILj1, respectively). Despite non-
significant interaction effects between these subgroups (P 9
0.10), standardized effect sizes (d) werej0.51 andj0.49 for
total cholesterol and LDL cholesterol, respectively.
Adipose tissue gene expression. Gene expression
data are presented in Figure 3. ATGL was down-regulated
over the course of 6 wk (day effect; P = 0.038). There
were no interaction effects (all P Q 0.08) for any of the
genes of interest.
DISCUSSION
Six weeks of home-based moderate-intensity arm-crank
exercise in inactive persons with chronic paraplegia signifi-
cantly improved (i) functional capacity (V˙O2peak and power
output), (ii) fasting insulin concentrations, and (iii) HOMA-IR
compared with the CON. Home-based exercise successfully
provided a considerable volume of structured exercise
(180 minIwkj1). Reduced insulin resistance was achieved
with a relatively modest increase in energy expenditure
(j109 T 85 kcalIdj1) and without concurrent improve-
ments in body composition.
Recent hand-cycle exercise training studies (1,18) have
demonstrated similar mean improvements in fasting insulin
concentrations, after 6- and 16-wk interventions in individuals
with SCI, to those reported herein. Although not calculated
using the updated HOMA2 model, these studies also showed
improvements in HOMA-IR. The only participant with
HOMA-IR above the cutoff (1.65) indicative of metabolic
TABLE 2. Body composition, resting physiological characteristics, free-living physical activity, and diet components measured at baseline and after 6 wk (follow-up) of CON or INTa.
CON (n = 8) INT (n = 13)
Baseline Follow-up $ (95% CI) Baseline Follow-up $ (95% CI)
Body mass, kg 76.8 T 11.3 76.1 T 10.6 j0.7 (j2.2 to 1.0) 76.8 T 13.3 75.7 T 13.8 j1.1 (j2.1 to j0.0)*
Fat mass (DEXA), kg 25.5 T 6.6 25.5 T 6.8 j0.0 (j0.7 to 0.7) 27.6 T 10.0 27.0 T 10.0 j0.6 (j1.4 to 0.2)
Lean mass (DEXA), kgb 47.7 T 10.5 47.2 T 10.5 j0.5 (j1.4 to 0.5) 45.6 T 7.5 45.3 T 7.0 j0.3 (j1.0 to 0.3)
VAT area, cm2 186 T 47 183 T 57 j3 (j14 to 9) 181 T 85 159 T 54 j22 (j58 to 14)
RMR, kcalIdj1 1483 T 224 1453 T 170 j30 (j88 to 29) 1452 T 191 1465 T 196 13 (j62 to 87)
Fasting RER 0.82 T 0.04 0.85 T 0.05 0.03 (j0.01 to 0.08) 0.81 T 0.04 0.80 T 0.03 j0.01 (j0.03 to 0.01)**
Systolic BP, mm Hg 128 T 15 126 T 12 j2 (j8 to 2) 128 T 23 125 T 21 j3 (j10 to 5)
Diastolic BP, mm Hg 81 T 13 77 T 10 j4 (j9 to 2) 77 T 15 76 T 12 j1 (j8 to 6)
PAEE, kcalIdj1c 342 T 171 340 T 179 j2 (j26 to 22) 324 T 161 433 T 195*** 109 (55 to 163)**
MVPA, minIwkj1c 152 T 207 136 T 187 j16 (j57 to 24) 91 T 91 212 T 136*** 121 (67 to 174)**
Energy intake, kcalIdj1 1658 T 299 1508 T 213 j150 (j509 to 208) 1704 T 477 1686 T 485 j18 (j214 to 179)
Carbohydrate intake, %) 44 T 6 44 T 7 0 (j4 to 3) 43 T 7 43 T 8 0 (j4 to 4)
Fat intake, % 35 T 3 36 T 6 1 (j3 to 5) 36 T 5 35 T 9.0 j1 (j5 to 3)
Protein intake, % 20 T 6 18 T 5 j2 (j6 to 1) 19 T 5 19 T 5 0 (j2 to 2)
Alcohol intake, % 1 T 2 2 T 2 1 (j1 to 3) 2 T 3 3 T 3 1 (j1 to 2)
None of the above variables differed significantly between groups at baseline. Moderate to large effect sizes were found between groups: fasting RER (d = j0.99), PAEE (d = 0.62), and
MVPA (d = 0.90).
aValues are means T SD. Change scores ($) shown with 95% CI.
bLean tissue mass excludes bone mineral content.
cCON (n = 7) and INT (n = 12). Missing data are the result of monitor failure or G4 valid measurement days.
*A main effect of day (i.e., baseline vs follow-up; P e 0.05).
**A day–group interaction (P e 0.05).
***Values are different pre–post within the INT group (P e 0.05).
BP, blood pressure; DEXA, dual-energy x-ray absorptiometry; MVPA, moderate-to-vigorous physical activity (Q3.0 METs); RMR, resting metabolic rate.
FIGURE 2—V˙O2peak (A) and workload (B) at baseline and after 6 wk
(follow-up) of CON or INT. Means T normalized CI are shown. The CI
values have been corrected to remove interindividual variation (22). †A
main effect of day (i.e., baseline vs follow-up for both groups; P e 0.001).
*A day–group interaction (P e 0.001). #Values are different pre–post
within the INT group (P e 0.001). There were moderate effect sizes between
groups of d = 0.68 and 0.61 for V˙O2peak (A) and workload (B), respectively.
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syndrome in persons with SCI (Academy of Spinal Cord Injury
Professionals Educational Conference and Expo poster, Hobson
et al., 2016) provides an illuminating case series. This partici-
pant displayed considerable improvements from 2.72 at base-
line to 1.50 at follow-up ($ j 1.21). A smaller volume of
upper-body moderate-to-vigorous aerobic exercise (40 min
minIwkj1) has recently been shown not to improve vascular
health or biomarkers of cardiovascular disease for 16 wk (8).
In light of the current study’s findings, it is possible that a
greater volume of upper-body exercise (than that proposed by
the PAG-SCI) might be necessary to promote beneficial ad-
aptations in insulin resistance.
There is a surprising paucity of research comparing dy-
namic glucose and insulin responses after arm-crank exercise
training in this population. However, changes in insulin sen-
sitivity after 16 wk of an arm-crank ergometry of 5 dIwkj1
were recently observed (14). High (70%–80% heart rate
reserve (HRR)) and low (40%–50% HRR) intensity arm-
crank ergometry have been shown to have detrimental or no
effect on insulin sensitivity, assessed using the HOMA–
continuous infusion of glucose with model assessment test
(6). These findings agree with measures derived from OGTT
data in this study, where no significant interaction effect was
evident. It has been suggested that insulin sensitivity indices
(i.e., ISIMatsuda), derived from an OGTT, predominantly rep-
resent peripheral insulin sensitivity (23), whereas HOMA-IR
reflects hepatic insulin sensitivity (29). Therefore, these data
could infer that moderate-intensity upper-body arm-crank
ergometry improves hepatic but not whole-body insulin sen-
sitivity. One explanation for improvements in hepatic insulin
sensitivity with exercise alone could be a reduction in intrahepatic
fat (32). Although a reduction in intrahepatic fat can be achieved
irrespective of weight loss (17), such responses have not been
observed over such a short duration of exercise training
FIGURE 3—Relative gene expression of 10 key metabolic genes measured in adipose tissue at baseline and follow-up for the CON group (n = 8) and
the INT group (n = 12). Dashed line represents no change. Data normalized to PPIA, baseline, and internal calibrator. Sufficient RNA could not be
obtained to carry out gene expression analysis for one participant follow-up sample (small adipose tissue yield); hence, n = 12 in the INT group. Values
are means T SEM. †A main effect of day (i.e., baseline vs follow-up for both groups; P e 0.05).
TABLE 3. Markers of metabolic regulation and cardiovascular disease risk measured at baseline and after 6 wk (follow-up) of CON or INTa.
CON (n = 8) INT (n = 13)
Baseline Follow-up $ (95% CI) Baseline Follow-up $ (95% CI)
Metabolic regulation
Fasted glucose, mmolILj1 5.7 T 1.3 5.7 T 1.2 0.0 (j0.2 to 0.2) 5.3 T 0.5 5.3 T 0.4 0.0 (j0.2 to 0.2)
Fasted insulin, pmolILj1 41.3 T 18.1 44.3 T 20.6 3.1 (j5.9 to 12.0) 54.8 T 30.1 42.1 T 13.2*** j12.7 (j24.0 to j1.4)*,**
HOMA2-IRb 0.80 T 0.35 0.86 T 0.40 0.06 (j0.10 to 0.23) 1.03 T 0.57 0.80 T 0.25*** j0.24 (j0.45 to j0.02)*,**
HOMA2-A, %b 66 T 23 67 T 22 1 (j10 to 13) 87 T 31 73 T 18 j14 (j26 to j2)
C-ISIMatsuda
c,d 6.4 T 3.1 5.7 T 2.3 j0.7 (j2.6 to 1.2) 4.8 T 2.2 5.1 T 1.8 0.3 (j0.7 to 1.2)
Plasma glycemic response, mmol per 120 minILj1d 293 T 252 268 T 228 j25 (j153 to 104) 252 T 271 271 T 242 19 (j48 to 86)
Serum insulinemic response, nmol per 120 minILj1d 40.6 T 21.6 42.8 T 16.0 2.2 (j11.6 to 16.0) 54.1 T 31.4 49.7 T 24.7 j4.4 (j19.0 to 10.2)
Cardiovascular disease risk
Total cholesterol, mmolILj1 5.1 T 0.9 5.2 T 1.1 0.1 (j0.5 to 0.5) 4.9 T 1.0 4.8 T 1.3 j0.1 (j0.5 to 0.4)
HDL cholesterol, mmolILj1 1.0 T 0.2 1.0 T 0.3 j0.0 (j0.1 to 0.1) 1.1 T 0.3 1.2 T 0.3 0.1 (j0.1 to 0.1)
LDL cholesterol, mmolILj1e 3.5 T 0.8 3.3 T 0.8 j0.2 (j0.6 to 0.2) 3.2 T 0.9 3.2 T 1.0 j0.0 (j0.4 to 0.3)
NEFA, mmolILj1d 0.7 T 0.6 0.6 T 0.6 j0.1 (j0.8 to 0.6) 0.6 T 0.3 0.9 T 0.6 0.3 (j0.2 to 0.8)
Triacylglycerol, mmolILj1 1.3 T 0.5 1.8 T 1.1 0.5 (j2.0 to 1.2) 1.2 T 0.5 1.1 T 0.5 j0.1 (j0.2 to 0.1)
None of the above variables differed significantly between groups at baseline.
aValues are means T SD. Change scores ($) shown with 95% CI.
bThe HOMA calculator, incorporating the updated HOMA-2 model (23), was used to derive fasting estimates of pancreatic A-cell function and insulin resistance.
cC-ISI Matsuda = 10,000/SQRT (fasted glucose in mgIdL
j1  fasted insulin in KIUImLj1)  (mean glucose over 120 min OGTT mgIdLj1  mean insulin over 120 min OGTT in KIUImLj1).
dCannula failure resulting in missing data; hence, n = 12 in the INT group.
eCalculated with the use of the Friedwald equation [LDL cholesterol = total cholesterol j HDL cholesterol j (triacylglycerol/2.2)].
*A day–group interaction (P e 0.05).
**A moderate effect size between groups (d = j0.69).
***Values are different pre–post within the INT group (P e 0.05).
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(i.e., 6 wk). Future research should therefore aim to elucidate
the mechanisms whereby upper-body exercise improves he-
patic insulin sensitivity in persons with SCI.
Convincing evidence that functional electronic stimulation–
leg cycling ergometry improves insulin sensitivity, deter-
mined from OGTT (ISICederholm) (5) and gold-standard
hyperinsulinemic–euglycemic clamp, is beginning to emerge
(15,16,24). In nondisabled individuals, it is well documented
that exercise training improves whole-body insulin sensitivity
and glucose homeostasis, with adaptations in skeletal muscle
being essential to this, because this tissue is responsible for
the majority of glucose utilization (7). Because voluntary
exercise is restricted to the smaller upper-body musculature
for persons with SCI, a large volume of exercise has a rela-
tively modest effect on whole-body energy expenditure and
associated weight loss (j1.1 T 1.7 kg). Therefore, training
adaptations specific to these smaller exercising muscle groups
might not provide a sufficient stimulus to overcome insulin
resistance in other peripheral tissues (i.e., leg skeletal muscle
and adipose tissue). For example, it was recently demon-
strated that arm-crank ergometry had no effect on protein ex-
pression changes of GLUT4, PGC-1>, and AMPK in
paralyzed vastus lateralis muscle (14). It therefore seems that
skeletal muscle adaptations to exercise are somewhat localized
and limited to the muscles activated during exercise training.
Dyslipidemia was common in our participants; 43% had
total cholesterol values of Q5 mmolILj1, 57% had elevated
LDL cholesterol (Q3 mmolILj1), and 62% had depressed
HDLcholesterol (e1.03mmolILj1 for men and e1.29 mmolILj1
for women). No significant differences were observed for total
cholesterol, LDL cholesterol, or HDL cholesterol. Although a
systematic review (4) concluded that there was insufficient
evidence suggesting that exercise alone improves dyslipidemia
in people with SCI, exercise at a higher-intensity might be
necessary to improve lipid profiles in this population (6,25).
Within the INT group, participants were stratified into two
subgroups on the basis of injury level. It was thought that those
with higher-level injuries (QT6) would have a greater degree of
functional impairment at baseline and thus potentially benefit
more from the INT. Mean $ change values responded differ-
ently between the two subgroups for total cholesterol and LDL
cholesterol, surprisingly, improving in those with an injury
level of GT6 and worsening in the QT6 group. Although these
finding were nonsignificant and based on a small subgroup
analysis, they are opposite to hypothesized and posit an inter-
esting message that persons with higher levels of injury/
impairment may not adapt in the sameway to exercise, perhaps
because of other biological limitations (i.e., loss of sympathetic
innervation). It has been demonstrated that inflammatory cyto-
kines and concentrations of epinephrine did not change in per-
sons with tetraplegia but were significantly elevated after an
acute bout of exercise in able-bodied controls and persons
with an SCI of GT6 (intact sympathetic innervation) (27).
Cytokines, such as interleukin 6, are released from skeletal
muscle in response to exercise (termed myokines) and play
an important role in regulating whole-body metabolism (28).
Therefore, loss of sympathetic innervation of the adrenal
medulla may diminish the metabolic responses to exercise in
persons with an SCI of QT6. Future studies are necessary to
confirm this.
To our knowledge, this is the first study to investigate the
expression of key genes within subcutaneous adipose tissue
involved in glucose and lipid metabolism in inactive persons
with chronic paraplegia. Across the 10 genes of interest, no
significant between-group responses were evident at the end
of the 6-wk period. In contrast, animal models have shown
that an exercise training stimulus can increase the expression
of genes involved in a variety of metabolic regulation and
mitochondrial biogenesis pathways (33,35). It is noteworthy
that some of these metabolic adaptations within adipose
tissue are independent of body mass changes (34). Because
of the reduced energy expenditure, cardiovascular strain,
and whole-body metabolic stress associated with upper-
body exercise in persons with SCI (25), it is extremely dif-
ficult to generate a considerable energy deficit through
exercise alone. It is therefore surprising that there is a lack of
research looking at the effect of dietary restriction alone, or in
combination with exercise, on cardiometabolic component
risks in this population. We encourage future work to inves-
tigate this, especially because a recent study has shown im-
provements in whole-body and adipose tissue metabolism for
as little as 3 wk with moderate weight loss (j2.4 kg),
achieved through a combination of exercise and dietary re-
striction in nondisabled overweight men and postmenopausal
women (38).
V˙O2peak and workload were significantly elevated in the
INT group by 17% ($, 3.4 mLIkgj1 Iminj1) and 20%, re-
spectively. These improvements in cardiorespiratory fitness are
greater than those observed (~10%) with a smaller volume of
moderate-intensity arm-crank exercise (~90 minIwkj1) during
a longer duration (12 wk) (10,30). A 3-mLIkgj1Iminj1 im-
provement in cardiorespiratory fitness has been associated with
greater than 15% and 19% reductions in all-cause and cardio-
vascular disease mortality in nondisabled individuals (20).
Although only measured for a week at baseline and before
follow-up, this is the first study to measure changes in free-
living behaviors (PAEE and energy intake) in response to an
exercise intervention in this population. At a group level, the
increase in estimated free-living PAEE (~109 kcalIdj1) mea-
sured during the final week of the intervention is similar to the
increase in PAEE (~98 kcalIdj1) estimated from baseline data.
However, there was considerable interindividual variability in
physical activity responses from baseline to follow-up in the
intervention group ($ in PAEE ranging fromj60 to 109, $ in
moderate-to-vigorous physical activity ranging from j4 to
32 minIdj1). It is conceivable that for some participants, the
prescribed exercise intervention simply replaced nonprescribed
(existing) physical activity of a similar intensity. This concept
has been referred to as ‘‘substitution’’ and may erode predicted
adaptations and observed changes in various outcome mea-
sures (i.e., body mass) (37). However, 67% of the INT group
performed more PAEE than predicted, which may indicate that
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substitution of behaviors was not as prevalent in this previously
inactive SCI cohort.
The main strength of the current study is the use of a
validated multisensor device, which permitted the screening
of inactive participants at baseline and the analysis of novel
concepts (i.e., substitution of physical activity) that had not
been looked at previously in persons with SCI. Every attempt
was made to recruit a relatively homogenous sample (i.e., in-
active, chronic paraplegia) with elevated cardiometabolic
component risks. Although participants were inactive, careful
assessment of lipid and glycemic profiles suggests that this
random sample of participants presented with fairly normal
cardiovascular disease risk profiles at baseline. Although this
may have resulted in either basement or ceiling effects, lipid
profile responses within the INT group did not respond dif-
ferently when participants were stratified into either high or
low risk on the basis of the National Cholesterol Education
Program Adult Treatment Panel III guidelines. To ensure a
more homogenous sample, more stringent inclusion criteria
could have been applied. However, this would likely have
negatively affected recruitment, which is an ongoing challenge
for researchers working with this population. As such, this is one
of the largest studies to assess the effect of moderate-intensity
arm-ergometry exercise on cardiometabolic component risks in
persons with SCI. Compared with previous research that has
predominantly focused on male participants, 29% of our co-
hort was female, which better reflects the sex distribution in
the wider population (US national statistics database).
CONCLUSIONS
In summary, our study shows that 6 wk of home-based
moderate-intensity arm-crank ergometry in inactive adults
with chronic paraplegia induced positive changes in func-
tional capacity and fasting insulin concentrations, as well as
improvements in hepatic insulin sensitivity. There were no
changes over time or differences between groups in markers
of peripheral insulin sensitivity, adipose tissue metabolism,
or other biomarkers of cardiovascular disease risk. Although
this intervention led to a modest increase in PAEE, we ob-
served beneficial metabolic adaptations, which seem to be
associated with improved liver function.
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